ALNYLAM PHARMACEUTICALS CEO Yvonne Greenstreet Sells Shares Worth $360.22 Each on Jan 12

Alnylam Pharmaceuticals Inc. (ALNY) announced that Chief Scientific Officer and Executive Vice President, Head of Research Fitzgerald Kevin Joseph sold a total of 2,339 shares on January 12 and 13, 2026, at various prices ranging from $353.95 to $377.82 per share. EVP Chief R&D Garg Pushkal also sold a total of 2,339 shares on the same dates at the same prices. Director and Chief Executive Officer Greenstreet Yvonne sold a total of 1,020 shares on January 12, 2026, at prices of $360.22 and $372.46 per share.